FGF-19 Antibody (11H3)
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-26584
Recombinant monoclonal antibody expressed in HEK293F cells
Key Product Details
Species Reactivity
Validated:
Human
Applications
ELISA, Western Blot
Label
Unconjugated
Antibody Source
Recombinant Monoclonal Rabbit IgG Clone # 11H3
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for FGF-19 Antibody (11H3)
Immunogen
A synthesized peptide derived from Human FGF-19 [UniProt O95750]
Clonality
Monoclonal
Host
Rabbit
Isotype
IgG
Scientific Data Images for FGF-19 Antibody (11H3)
Western Blot: FGF-19 Antibody (11H3) [NBP3-26584] -
Western Blot: FGF-19 Antibody (11H3) [NBP3-26584] - Positive Western Blot detected in: Ntera-2 whole cell lysate, Hela whole cell lysate, HepG2 whole cell lysate, A549 whole cell lysate.All lanes: FGF-19 Antibody at 1: 500
Secondary: Goat polyclonal to rabbit IgG at 1/50000 dilution.
Predicted band size: 25 kDa
Observed band size: 36 kDa
Applications for FGF-19 Antibody (11H3)
Application
Recommended Usage
Western Blot
1:500-1:2000
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Affinity purified
Formulation
PBS, pH 7.4, 150mM NaCl and 50% glycerol
Preservative
0.02% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at -20 to -70C. Avoid freeze-thaw cycles.
Background: FGF-19
Long Name
Fibroblast Growth Factor 19
Alternate Names
FGF19
Gene Symbol
FGF19
Additional FGF-19 Products
Product Documents for FGF-19 Antibody (11H3)
Product Specific Notices for FGF-19 Antibody (11H3)
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...